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Given the susceptibility of the fetus to toxicants, it is important to estimate their exposure. Approxi-
mately 2000 pregnant womenwere recruited in 2008e2011 from 10 cities across Canada. Cd, Pb, Mn and
total Hg were measured in maternal blood from the 1st and 3rd trimesters, umbilical cord blood, and
infant meconium. Nutrient intakes of vitamin D, iron, and calcium (Ca) were assessed using a food
frequency questionnaire and a dietary supplement questionnaire.
Median concentrations in 1st trimester maternal blood (n ¼ 1938) were 0.20, 8.79 and 0.70 mg/L for Cd,
Mn and Hg, respectively, and 0.60 mg/dL for Pb. While the median difference between the paired 1st and
3rd trimester concentrations of Cd was 0, there was a signiﬁcant decrease in Pb (0.04 mg/dL) and Hg
(0.12 mg/L) and an increase in Mn (3.30 mg/L) concentrations over the course of the pregnancy. While Cd
was rarely detected in cord blood (19%) or meconium (3%), median Pb (0.77 mg/dL), Mn (31.87 mg/L) and
Hg (0.80 mg/L) concentrations in cord blood were signiﬁcantly higher than in maternal blood. Signiﬁcant
negative associations were observed between estimated Ca intake and maternal Cd, Pb, Mn and Hg, as
well as cord blood Pb. Vitamin D intake was associated with lower maternal Cd, Pb, and Mn as well as Pb
in cord blood.
Even at current metal exposure levels, increasing dietary Ca and vitamin D intake during pregnancy
may be associated with lower maternal blood Pb and Cd concentrations and lower Pb in cord blood.
Crown Copyright © 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).n, Healthy Environments and
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Various metals, including cadmium (Cd), lead (Pb), manganese
(Mn), and mercury (Hg) are found in our environment and food,icle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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nadian general population have shown some temporal variability.
Comparing cycles of the Canadian Health Measures Survey be-
tween 2007 and 2013, there was no signiﬁcant difference in blood
Cd or Hg, but Pb concentrations declined (geometric means 1.3 to
1.1 mg/dL) (Health Canada, 2015). Geometric means of blood Mn
concentrations increased between 2007 and 2011 (9.2e9.8 mg/L)
(Health Canada, 2013b). While levels of metals such as Pb in most
environmental media and products have declined over the past few
decades, Canadians can still be exposed to Pb in food, drinking
water, air, dust, soil and manufactured products (Health Canada,
2013a), to Cd from cigarette smoke and diet (J€arup and Åkesson,
2009), to Hg from certain ﬁsh species and dental amalgam ﬁllings
(Health Canada, 2009), and to Mn from a variety of foods and from
nutritional supplements, but also in air, water and soil (ATSDR,
2012). Manganese is also a required trace element and an impor-
tant antioxidant nutrient in pregnancy (Mistry andWilliams, 2011).
A recent review of the epidemiologic literature has reported
associations between maternal exposures to: Pb and low birth
weight, preterm birth, stillbirths, spontaneous abortions and hy-
pertension; Cd and low birth weight, neurological dysfunction and
lowApgar score; and Hg and spontaneous abortions and neurotoxic
effects (Rahman et al., 2016). Furthermore, the toxicity of Pb ap-
pears to increase in the presence of higher levels of Cd, Mn or Hg
(reviewed in Claus Henn et al., 2014). Elevated concentrations of
blood Mn during pregnancy have been associated with gestational
hypertension (Vigeh et al., 2013) and may also affect birth weight
(Zota et al., 2009).
The placenta, which acts as an interface between maternal cir-
culation and the fetus, also protects the embryo by ﬁltering the
passage of pollutants. However, while a number of metals such as
Pb and Hg can cross the placental barrier, it is less clear for Cd
(Caserta et al., 2013).
Nutrient intake may impact the toxicokinetics of metals by
reducing the absorption or toxicity of toxic metals such as Pb and
Cd (Hong et al., 2014; Liu et al., 2013; Nishijo et al., 2004; Gulson
et al., 2016; Ettinger et al., 2009; Åkesson et al., 2002). Analysis of
maternal and infant biospecimens for chemical biomarkers pro-
vides an opportunity to estimate the extent of exposure for both the
pregnant woman and her fetus to environmental chemicals during
critical periods of development. There are limited data available
which prospectively track exposure to current levels of metals
across pregnancy and at birth in a large population. To address this
dearth, the Maternal-Infant Research on Environmental Chemicals
(MIREC) Study was designed to generate national-level data on
maternal and newborn exposure to priority environmental con-
taminants, including metals (Arbuckle et al., 2013).
The goals of this analysis were to describe exposure of pregnant
women and their infants to these metals and to examine the
possible effects of nutrient intake on metal levels. The MIREC Study
offers a unique opportunity to do this as metals were measured in
1st and 3rd trimester blood samples, umbilical cord blood and
meconium in a large national-level Canadian pregnancy cohort. In
addition, given the health concerns about excess exposure to these
metals, determining whether current levels are moderated by
maternal nutrient intakes will make an important contribution to
possible public health interventions.
2. Methods
2.1. Study population
A cohort of pregnant women (n ¼ 2001) was recruited over 4
years (2008e2011) from obstetric and prenatal clinics in ten cities
across Canada, as part of the Maternal-Infant Research onEnvironmental Chemicals (MIREC) Study. Eligibility criteria
included: less than 14 weeks gestation; ability to consent and to
communicate in English or French; age 18 years or older; planning
on delivering locally; and agreeing to participate in the cord blood
collection component of the MIREC Study. Women with a medical
history of any of the followingwere excluded from the study: major
chronic disease; threatened abortion; and illicit drug use. Details on
the cohort have been previously described (Arbuckle et al., 2013).
The study was reviewed and approved by the Health Canada
Research Ethics Board and the ethics committees at the partici-
pating hospitals and research centers across Canada. Potential
participants were provided with information on the objectives and
design of the study and asked to sign informed consent prior to
participation.
2.2. Data collection and determination of nutrient intake
Questionnaires were administered during the 1st and 3rd
trimester study visits to collect information on the characteristics of
the participants (e.g., maternal age and education, household in-
come, pre-pregnancy body mass index (BMI), parity, country of
birth, and smoking status). The season in which the blood was
collected and whether it was a fasting sample were also noted.
At the second trimester visit, between 16 and 21 weeks of
pregnancy, a semi-quantitative food frequency questionnaire (FFQ)
with a one-month recall period was administered to obtain a
ranking of iron (Fe), calcium (Ca) and vitamin D intakes for each
individual. The methodology used to obtain the nutrient intake has
been previously described (Morisset et al., 2016). Brieﬂy, for each
food item, information on the frequency and serving size consumed
were collected and each food was matched to corresponding foods
in the 2010 Canadian Nutrient File (Health Canada, 2010a). The
serving size, gram weight and the amount of nutrient were calcu-
lated for each serving of the food item reported.
Participants also completed a nutrient supplement question-
naire around 16 weeks gestation that asked for a detailed list of
dietary supplements taken in the last 30 days (brand name and
description of product, amount taken each time and frequency).
Supplement Fe, Ca and vitamin D content were derived using
Health Canada's Drug Product database (http://www.hc-sc.gc.ca/
dhp-mps/prodpharma/databasdon/index-eng.php) and/or the
detailed ingredients list from the product monograph. Intakes from
food and supplements were summed to derive quartile estimates of
total intake.
2.3. Biospecimen collection and metal analysis
Maternal 1st (6e13 wks) and 3rd (32e34 wks) trimester whole
blood was collected in 6 mL K2EDTA tubes and aliquotted into 5 mL
Sarstedt® tubes (Sarstedt AG & Company, Nümbrecht, Germany)
and frozen at 20 C. Venous umbilical cord blood was collected
using a Sarstedt® S- Monovette, inverted 8e10 times, transferred to
5 mL Sarstedt® tubes and frozen at 20 C. Mere Helene® bioliners
(Mere Helene, Quebec Canada) were inserted in the diapers and
meconium was transferred to 50 mL Sarstedt® tubes and frozen
at 20 C. Biospecimens were shipped frozen to the Centre de
Toxicologie du Quebec, Institut National de Sante Publique du
Quebec (INSPQ), Quebec QC, Canada for analysis.
2.3.1. Instrumentation
All biological samples (blood, cord blood and meconium) were
analyzed using a single-quadrupole PerkinElmer (Waltham, MA
USA) Elan DRCII ICP-MS (inductively coupled plasma-mass spec-
trometry) system operated in standard mode. The system was
equipped with a cyclonic spray chamber, an Elemental Scientiﬁc
T.E. Arbuckle et al. / Chemosphere 163 (2016) 270e282272MicroFlow PFA-ST nebulizer and a quartz torch. Lens and gas ﬂow
parameters of the ICP-MS were daily optimized to maximize
sensitivity while maintaining oxides and double charges low (CeO/
Ce  3.2%; Baþþ/Ba  3%). Sample preparation and analysis were
carried out in the INSPQ laboratory that was speciﬁcally designed
and dedicated to trace element analysis.
The analytical methods were fully developed and validated for
monitoring purposes following 17025 ISO guidelines. The method
limits of detection (LOD) for all elements (shown in Table 1) were
determined by using a signal to noise ratio of 3 from 10 consecutive
measurements of a representative sample. When several detection
limits were present, the highest LOD is presented in the tables.
2.3.2. Field blanks
Prior to the biospecimen collection, all collection materials were
screened for the elements of interest using a validated method for
trace metals. During the ﬁeld work, ﬁeld blanks were utilized to
assess potential risks of contamination bymimicking the process of
collection and handling of biospecimens at recruitment sites,
transportation, storage and laboratory analysis, using steril.O re-
agent grade deionized distilled water as the matrix. Results showed
that the ﬁeld blanks were free of contamination, with the exception
of Mn; a value of 14 nmol/L was subtracted from each Mn value
prior to recording the result.
2.3.3. Blood and cord blood analysis
Maternal blood samples (500 mL) were diluted 20-fold and cord
blood (250 mL) 40-fold in a diluent containing 0.5% (v/v) NH4OH and
0.1% (v/v) octylphenol ethoxylate. External calibration curves were
prepared by diluting 20-fold (for blood) and 40-fold (for cord
blood) respectively, the corresponding volume of human blood
(from healthy volunteers) with diluent and then spiking with
different volumes of 1 mg/L multi-elements standard solution (SCP
Science, PlasmaCal ICP-MS Veriﬁcation Standard 1; 5% HNO3, #141-
110-011). The internal standards for the calibration curve and the
blood samples analysis were 89Y (for 55Mn), 103Rh (for 114Cd), 159Tb
(for 208Pb) and 195Pt (for 202Hg). Internal quality assurance was
ensured by running validated reference materials (QMEQAS08B05,
QMEQAS08B08, QM-B-Q1108 and QM-B-Q1201 - human blood
from the QMEQAS inter-laboratory comparison scheme) after
calibration, after every 10th sample and at the end of each
analytical sequence.Table 1
Descriptive statistics for metals in maternal, cord blood and meconium using censoring
Metal Sample N LOD %<LOD Min Median 95t
Cadmium (Cd) (mg/L) 1st trimester 1938 0.0450 2.63 ND 0.2023 1.12
3rd trimester 1673 0.0450 3.89 ND 0.2023 0.74
Cord blood 1420 0.1124 80.77 ND ND 0.22
Meconium a 1591 0.004 97.36 ND ND ND
Lead (Pb) (mg/dL) 1st trimester 1938 0.1036 0 0.1554 0.6009 1.40
3rd trimester 1673 0.1036 0.18 ND 0.5595 1.37
Cord blood 1419 0.2072 2.61 ND 0.7667 b 1.69
Meconium a 1591 0.004 79.38 ND ND 0.00
Manganese (Mn) (mg/L) 1st trimester 1938 0.5495 0 2.0330 8.7912 14.8
3rd trimester 1673 0.5495 0 2.4725 12.6374 20.3
Cord blood 1419 0.5495 0 5.4945 31.8681b 54.9
Meconium a 1591 0.01 0 0.24 4.9 15
Total mercury (Hg) (mg/L) 1st trimester 1938 0.1204 9.80 ND 0.7021 2.80
3rd trimester 1673 0.1204 11.24 ND 0.5617 2.28
Cord blood 1419 0.4012 28.19 ND 0.8024 b 3.61
Meconium a 1591 0.01 75.11 ND ND 0.02
LOD: limit of detection.
ND: not detected (<LOD).
NA: not calculated as more than 70% of the observations were < LOD.
a Unit for levels of heavy metals in meconium is mg/g.
b Signiﬁcantly higher than maternal median concentrations (p < 0.0001).2.3.4. Meconium analysis
Meconium was homogenized and then samples (500 mg) were
predigested at room temperature in a Teﬂon bomb for 3 h under
acidic conditions (2 mL HNO3). The bombs were then sealed and
placed at 110 C for 18 h to complete the digestion. The digest was
diluted 50-fold with an aqueous solution (diluent) containing
0.002% (m/v) L-(þ)-cysteine and 100 mgL-1 Au. External calibration
curves were prepared in 2% (v/v) HNO3 containing 0.002% (m/v) L-
(þ)-cysteine and 100 mgL-1 Au by spiking with different volumes of
1 mg/L multi-elements standard solution (SCP Science, PlasmaCal
ICP-MS Veriﬁcation Standard 1; 5% HNO3, #141-110-011). The in-
ternal standards for calibration standards and meconium samples
were 89Y (for Mn), 103Rh (for Cd), 159Tb (for Pb) and 195Pt (for Hg).
Internal quality assurance was ensured by running standard refer-
ence materials (SRM 1577 b - bovine liver from NIST) and validated
reference materials (QM-H-Q1101 - human hair from the QMEQAS
external quality assessment scheme) after calibration, after every
10th sample and at the end of each analytical sequence.
2.4. Statistical analysis
Substitution methods for dealing with laboratory results below
the method's LOD, such as LOD/2 or LOD/√2 may lead to increased
bias and an underestimation of the error variance, resulting in low
power for statistical hypothesis testing (Cole et al., 2009; Leith
et al., 2010; May et al., 2011; Helsel, 2012; Nysen et al., 2012). To
mitigate these issues, we applied survival analysis techniques for
right censored data to the left-censored scenario to better account
for the values below the LOD using either parametric maximum
likelihood estimation (MLE) or nonparametric Kaplan-Meier (KM)
and generalizedWilcoxon tests (Helsel, 2012). Maximum likelihood
depends on distributional assumptions, such as log-normality and
may be inefﬁcient with small sample sizes; in the latter cases, non-
parametric methods were used for analysis. As most of the metals
had some values below the LOD, both censoring methods were
implemented for descriptive statistics and hypothesis testing. The
geometric mean from a lognormal random variable with censoring
was calculated using the MLE method, while the median was
calculated using the Kaplan-Meier approach. The Greenwood esti-
mate of variance was used for determination of Kaplan-Meier
conﬁdence intervals. The parametric and nonparametric
censoring methods were used only for metals with at least 50% ofmethods.
h percentile Max KM median 95% CI GM MLE 95% CI
4 5.6199 0.2023 0.1953 0.2093 0.2197 0.2118 0.2278
18 4.2711 0.2023 0.1957 0.2089 0.2005 0.1934 0.2078
48 4.0463 NA NA NA NA NA NA
0.1300 NA NA NA NA NA NA
9 5.1803 0.6009 0.5851 0.6167 0.6205 0.6075 0.6338
59 4.1442 0.5595 0.5447 0.5742 0.5728 0.5589 0.5870
91 5.1803 0.7667 0.7443 0.7890 0.7483 0.7284 0.7688
85 0.48 NA NA NA NA NA NA
352 29.1209 8.7912 8.6462 8.9362 8.7974 8.6733 8.9232
297 33.5165 12.6374 12.4138 12.8609 12.2608 12.0679 12.4568
451 98.9011 31.8681 31.1883 32.5479 31.4586 30.8846 32.0434
40 4.9 4.6816 5.1184 4.4996 4.3279 4.6782
84 10.0301 0.7021 0.6624 0.7418 0.6133 0.5842 0.6438
69 12.4373 0.5617 0.5287 0.5947 0.4965 0.4726 0.5216
08 14.2427 0.8024 0.7428 0.8620 0.7659 0.7264 0.8075
5 0.14 NA NA NA NA NA NA
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the non-normality of the data, Wilcoxon signed rank test or sign
test were used to test whether the medians of the two measure-
ments (1st and 3rd trimesters) were equal.
Spearman correlations for each metal were calculated between
each sampling period and matrix and the intraclass correlation
coefﬁcients (ICCs) were calculated to examine within-woman
variability between the 1st and 3rd trimester metal concentrations.
Statistical hypothesis testing was used to test for signiﬁcant
differences among demographic groups. The maximum likelihood
estimation (MLE) was employed to account for leftecensored
repeated measures, analogous to Jin et al. (2011) and Thiebaut and
Jacqmin-Gadda (2004) using the NLMIXED procedure in SAS. Hy-
pothesis testing was performed using both the 1st and 3rd
trimester data for metals having at least 50% of the observations
above the LOD using likelihood ratio testswhich followa chi-square
distribution. The Bonferroni multiple comparison technique was
used when overall tests were signiﬁcant. In addition, geometric
mean maternal and cord blood metal concentrations were calcu-
lated by quartile categories of selected nutrients (Ca, Fe and vitamin
D intake and maternal blood Mn). To test signiﬁcant differences
among nutrient groups, analysis of variance was performed. When
the overall F-test for variables which have more than two groups
was signiﬁcant, Scheffe multiple pair-wise comparisons were used
to determine which groups were signiﬁcantly different from one
another. In addition, simple linear regression analyses were per-
formed to examine the relationships betweenmetal concentrations
and each nutrient. A residual analysis was implemented to verify
the statistical assumptions of normality and constant variance.
When these assumptions were not satisﬁed for the log-
transformed data, nonparametric regression was used. Statistical
analysis was performed using SAS (Statistical Analysis System)
Enterprise Guide 4.2 and R (R Core Development Team). For the
censoring methods, functions from the R packages NADA and
SURVIVAL and SAS procedure NLMIXED were used for analysis.
Unless otherwise indicated, a 5% signiﬁcance level (a ¼ 0.05) was
implemented throughout.
3. Results
3.1. Descriptive statistics on metals in maternal-fetal unit
Among the 2001 women recruited, 18 withdrew, and 1st
trimester maternal blood metal data were available for 1938
women. A description of the study population is shown in
Supplemental Material Table S1. The majority of the women were
30 years or older, had never smoked, were primigravida or secun-
digravida, were born in Canada, had a normal or underweight BMI
and were well educated. The male:female birth ratio was 1.096.
Most of the women had detectable concentrations of Pb, Cd, Mn
and total Hg in their blood (Table 1). Maternal blood Cd concen-
trations ranged from below the LOD to 5.62, with a median of
0.20 mg/L. Cadmium was not detected in 80% of the cord blood and
97% of the meconium samples. GM concentrations of Pb in
maternal blood were 0.62 and 0.57 mg/dL for 1st and 3rd trimesters,
respectively, and 0.75 mg/dL in cord blood. Manganese concentra-
tions increased over the course of the pregnancy and were highest
in cord blood. Total mercury was detected in approximately 90% of
maternal blood samples but only 25% of meconium samples (even
with a more sensitive LOD in meconium than in blood). Median
cord blood Pb, total Hg and Mn concentrations were statistically
higher than maternal concentrations at 1st and 3rd trimesters.
The relative comparison of metal concentrations in thematernal
and cord blood provides an indication of the exposure of the fetus,
which may experience more or less exposure based both on themother's exposure and the extent of placental transfer. Moderate to
high correlations were observed between 1st and 3rd trimester
maternal blood metal concentrations, as well as between maternal
and cord blood for all metals except Cd (Supplemental Material
Table S2). Linear regression analysis also showed positive associa-
tions between log maternal and cord blood metal levels, with
somewhat stronger associations between cord and 3rd trimester
than between cord and 1st trimester blood metals (Supplemental
Figs. S1 and S2). Supplemental Fig. S3 shows the cumulative dis-
tribution for the difference (A) and ratio (B) between maternal 3rd
trimester and cord blood concentrations (ug/L) for the four metals.
Observing the differences (A), it appears that Cd and Hg concen-
trations tend to equilibrate in maternal and cord blood while Pb
and Mn concentrations show greater variability between mother
and fetus/infant; however, the greater variability of differences
betweenmother and fetus/infant for Pb andMn (compared with Cd
and Hg) is probably because concentrations of Pb and Mn are much
larger than those of Cd and Hg. The ratio (B) of maternal-to-cord
blood concentrations indicates that the extent of transfer varies
considerably both among and between themetals, with themedian
ratios varying from about 3.2 for Cd to 0.4 for Mn.
The intraclass correlation coefﬁcients and 95% conﬁdence in-
tervals between 1st and 3rd trimesters were 0.81 (0.79, 0.82), 0.73
(0.71, 0.76), 0.29 (0.24, 0.33) and 0.60 (0.57, 0.63) for Cd, Pb, Mn and
Hg, respectively. While the median difference between the paired
1st and 3rd trimester concentrations of Cd was 0.0 mg/L, there was a
signiﬁcant decrease in Pb (0.04 mg/dL) and Hg (0.12 mg/L) and an
increase in Mn (3.30 mg/L) concentrations over the course of the
pregnancy (Supplemental Material Table S3).
For this study, we considered maternal blood Pb, Cd, and Hg
concentrations at or exceeding 4 mg/dL, 5.1 mg/L and 8 mg/L,
respectively, reportable and a copy of the individual's results were
shared with the participant's health care provider for follow-up.
Less than 1% of the women had blood Pb, Cd or Hg concentra-
tions at or exceeding the MIREC reporting levels.
3.2. Factors associated with maternal blood metal levels
Women less than 25 years of age had signiﬁcantly higher blood
Cd concentrations, while older women had higher blood Pb; GM
concentrations for Hg increased with increasing age (Table 2).
Women who had never smoked had signiﬁcantly lower blood Cd
and Pb, whereas Mn levels were higher in never smokers and Hg
was lowest in current smokers or who had recently quit. Higher
blood Cd concentrations were observed in women who were less
educated and had lower household incomes. Obese women had
higher blood Mn and lower Hg. Mercury geometric mean blood
concentrations were also positively associated with household in-
come. Maternal Cd and Pb blood concentrations were signiﬁcantly
lower when collected in the spring compared to summer months.
Maternal country of birth outside Canada was signiﬁcantly
associated with elevated levels of all metals (Table 2). A further
examination showed that women born in Canada had signiﬁcantly
lower GM Cd than women born in Asian countries, lower Pb than
women born in Africa, Asia, the Caribbean, Eastern Europe and
Europe, lower Mn than women born in Asia, and lower Hg than
women born in Asia, the Caribbean, Central or South America and
Europe (Supplemental Material, Table S4).
3.3. Factors associated with fetal exposure
Among the three metals with sufﬁcient detection in cord blood,
Mn and Hgwere signiﬁcantly higher inmale infants than in females
(Table 3). Similar to maternal blood concentrations, cord blood Hg
was signiﬁcantly lower in current smokers. Of the metals, only Mn
Table 2
Univariate predictors of maternal blood metal concentrations (mg/L) based on data from 1st and 3rd trimesters (n ¼ 3611).
Characteristic Na Cadmium Lead
p-value Pairwiseb GM (95% CI) p-value Pairwiseb GM (95% CI)
Maternal age
<25 244 0.0001 A 0.2655 (0.2254, 0.3128) <0.0001 A 0.5383 (0.4858, 0.5965)
25e29 848 B 0.2021 (0.1848, 0.2209) A 0.5433 (0.5137, 0.5747)
30e34 1290 B 0.2026 (0.1885, 0.2177) A 0.5807 (0.5550, 0.6076)
35 1229 B 0.2218 (0.2060, 0.2388) B 0.6729 (0.6423, 0.7048)
Parity
0 1604 0.0222 A 0.2209 (0.2082, 0.2343) 0.0070 A 0.6198 (0.5970, 0.6435)
1 1447 B 0.2015 (0.1894, 0.2143) B 0.5773 (0.5551, 0.6005)
2+ 557 AB 0.2212 (0.2002, 0.2444) AB 0.5921 (0.5557, 0.6309)
Maternal smoking status
Current/quit during pregnancy 427 <0.0001 A 0.5933 (0.5398, 0.6520) 0.0007 A 0.6281 (0.5854, 0.6739)
Former 974 B 0.2081 (0.1953, 0.2217) A 0.6284 (0.5992, 0.6590)
Never 2205 C 0.1752 (0.1680, 0.1828) B 0.5790 (0.5608, 0.5978)
Maternal education
High school or less 309 <0.0001 A 0.3586 (0.3152, 0.4081) <0.0001 A 0.6076 (0.5588, 0.6608)
College courses or diploma 1031 B 0.2200 (0.2049, 0.2362) B 0.5489 (0.5241, 0.5749)
University degree 2267 C 0.1948 (0.1856, 0.2044) A 0.6210 (0.6018, 0.6409)
Place of birth
Elsewhere 677 0.0281 A 0.2294 (0.2129, 0.2471) <0.0001 A 0.7489 (0.7152, 0.7843)
Canada 2934 B 0.2091 (0.2018, 0.2167) B 0.5679 (0.5555, 0.5806)
Pre-pregnancy BMI (kg/m2)
<25 (underweight-normal) 2141 0.2540 0.2155 (0.2049, 0.2266) 0.0001 A 0.6171 (0.5974, 0.6374)
25e29 (overweight) 720 0.2073 (0.1902, 0.2259) B 0.5641 (0.5337, 0.5962)
30 (obese) 487 0.1999 (0.1800, 0.2221) B 0.5526 (0.5164, 0.5913)
Household income
 $50,000 618 <0.0001 A 0.2634 (0.2404, 0.2887) 0.0022 A 0.6389 (0.6021, 0.6781)
$50,001e100,000 1433 B 0.2056 (0.1934, 0.2184) B 0.5764 (0.5541, 0.5996)
> $100,000 1398 B 0.1941 (0.1825, 0.2064) AB 0.6023 (0.5786, 0.6269)
Season blood collected
Fall 995 0.0007 AB 0.2105 (0.1984, 0.2234) <0.0001 A 0.6184 (0.5965, 0.6411)
Winter 826 B 0.2180 (0.2046, 0.2323) B 0.5885 (0.5663, 0.6115)
Spring 947 A 0.2002 (0.1885, 0.2127) B 0.5731 (0.5525, 0.5945)
Summer 843 B 0.2247 (0.2110, 0.2394) A 0.6117 (0.5888, 0.6355)
Fasting status
No 3532 0.0706 0.2122 (0.2054, 0.2192) 0.0952 0.5971 (0.5849, 0.6095)
Yes 69 0.2427 (0.2097, 0.2811) 0.6418 (0.5891, 0.6992)
Characteristic Na Manganese Total mercury
p-value Pairwiseb GM (95% CI) p-value Pairwiseb GM (95% CI)
Maternal age
<25 244 0.8624 10.3125 (9.6259, 11.0481) <0.0001 A 0.2650 (0.2123, 0.3309)
25e29 848 10.1628 (9.7915, 10.5481) B 0.4064 (0.3606, 0.4580)
30e34 1290 10.1808 (9.8784, 10.4923) C 0.5505 (0.5000, 0.6061)
35 1229 10.2915 (9.9785, 10.6143) D 0.7873 (0.7136, 0.8686)
Parity
0 1604 0.0277 A 10.0181 (9.7758, 10.2664) 0.3286 0.5687 (0.5236, 0.6178)
1 1447 B 10.3829 (10.1190, 10.6537) 0.5451 (0.4998, 0.5945)
2+ 557 AB 10.4172 (9.9938, 10.8585) 0.5156 (0.4484, 0.5929)
Maternal smoking status
Current/quit during pregnancy 427 0.0002 A 9.5655 (9.1269, 10.0251) <0.0001 A 0.4112 (0.3523, 0.4798)
Former 974 AB 10.0944 (9.7837, 10.4150) B 0.6084 (0.5483, 0.6751)
Never 2205 B 10.4176 (10.2029, 10.6369) B 0.5579 (0.5201, 0.5984)
Maternal education
High school or less 309 0.8995 10.2576 (9.7031, 10.8438) <0.0001 A 0.3147 (0.2623, 0.3775)
College courses or diploma 1031 10.1732 (9.8673, 10.4886) B 0.4506 (0.4078, 0.4979)
University degree 2267 10.2415 (10.0321, 10.4553) C 0.6529 (0.6102, 0.6986)
Place of birth
Elsewhere 677 <0.0001 A 10.9977 (10.6650, 11.3408) <0.0001 A 0.9061 (0.8191, 1.0022)
Canada 2934 B 10.0534 (9.9063, 10.2027) B 0.4913 (0.4680, 0.5158)
Pre-pregnancy BMI (kg/m2)
<25 (underweight-normal) 2141 0.0256 A 10.1639 (9.9496, 10.3829) <0.0001 A 0.6155 (0.5737, 0.6605)
25e29 (overweight) 720 A 10.0994 (9.7365, 10.4759) B 0.5253 (0.4658, 0.5924)
30 (obese) 487 B 10.7119 (10.2445, 11.2007) C 0.3998 (0.3449, 0.4635)
Household income
 $50,000 618 0.3504 10.2688 (9.8727, 10.6809) <0.0001 A 0.4246 (0.3728, 0.4836)
$50,001e100,000 1433 10.2995 (10.0357, 10.5701) B 0.5071 (0.4653, 0.5528)
> $100,000 1398 10.0816 (9.8200, 10.3501) C 0.6795 (0.6227, 0.7414)
Season blood collected
Fall 995 0.0004 A 10.1519 (9.8500, 10.4630) <0.0001 A 0.5580 (0.5165, 0.6029)
Winter 826 AC 9.8634 (9.5429, 10.1947) AB 0.5142 (0.4736, 0.5583)
Spring 947 AB 10.5369 (10.2163, 10.8676) AB 0.5295 (0.4895, 0.5728)
Summer 843 AB 10.3193 (9.9872, 10.6623) AC 0.6026 (0.5554, 0.6538)
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Table 2 (continued )
Characteristic Na Manganese Total mercury
p-value Pairwiseb GM (95% CI) p-value Pairwiseb GM (95% CI)
Fasting status
No 3532 0.4685 10.2256 (10.0886, 10.3645) 0.5120 0.5492 (0.5249, 0.5747)
Yes 69 9.9111 (9.1132, 10.7789) 0.5824 (0.4875, 0.6958)
a Number of blood samples.
b Results of statistical hypothesis testing of differences by group characteristics: groups with same letter indicate levels are statistically similar, whereas groups with
different letters represent signiﬁcant differences.
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ciations and neither infant sex, maternal smoking or season of
collection were signiﬁcantly associated with Mn concentrations in
meconium (data not shown).3.4. Nutrient-metal associations
Although most of the r-squares of the simple regressions were
1%, a number of signiﬁcant trends were observed between nu-
trients and 3rd trimester metal concentrations in blood
(Supplemental Tables). Maternal blood Cd, Pb and Hg concentra-
tions increased signiﬁcantly with quartiles of blood Mn concen-
trations (Table 4) and in the regression analysis (Supplemental
Table S5). No signiﬁcant association was observed between
maternal Mn concentration in the 3rd trimester and Pb and Hg
concentrations in cord blood; however, a signiﬁcant positive as-
sociationwas observed betweenmaternal bloodMn and cord blood
Mn.
Ca intake was negatively associated with 3rd trimester maternal
blood Cd, Pb, Mn and Hg, as well as cord blood Pb, according to the
regression analysis (Supplemental Table S6). The GMs of maternal
metal concentrations of Pb were signiﬁcantly different by quartiles
of Ca intake; however, we could not state which group GM was
signiﬁcantly lower than the other group means based on the
Scheffe test (Table 5).
Although not consistent across quartiles (Table 6), higher esti-
mates of Fe intake were signiﬁcantly associated with higher blood
Hg concentrations in the regression analysis (Supplemental
Table S7). The 3rd quartile of Fe intake was associated with
signiﬁcantly lower blood Mn than the 1st quartile of intake.
Vitamin D intake was signiﬁcantly associated with lower
maternal blood Cd, Pb, and Mn, and lower Pb in cord blood in the
regression analysis (Supplemental Table S8). Compared to the 4th
quartile of vitamin D intake, the 1st quartile was associated withTable 3
Predictors of cord blood metal concentrations (mg/L) (n ¼ 1415).
Characteristic Manganese Lead
p-value Pairwisea GM (95% CI) p-value P
Infant gender
Male (n ¼ 751) 0.0002 A 32.4737 (31.6664, 33.3016) 0.5037
Female (n ¼ 664) B 30.2640 (29.4658, 31.0838)
Maternal smoking
Current (n ¼ 152) 0.1745 30.6826 (28.6623, 32.8453) 0.7235
Former (n ¼ 371) 30.6651 (29.3493, 32.0400)
Never (n ¼ 833) 31.8170 (30.9004, 32.7609)
Season of collection
Fall (n ¼ 339) 0.8491 31.8722 (30.2916, 33.5353) <0.0001 A
Winter (n ¼ 321) 31.2758 (29.6850, 32.9519) A
Spring (n ¼ 392) 31.2917 (29.8426, 32.8111) A
Summer (n ¼ 364) 31.1967 (29.7033, 32.7651) B
a Results of statistical hypothesis testing of differences by group characteristics: gro
different letters represent signiﬁcant differences.signiﬁcantly higher 3rd trimester blood Cd and Mn concentrations
(Table 7).4. Discussion
4.1. Metals in the maternal-fetal unit
Only limited mother-child paired data have been published on
the partitioning of Pb, Cd, Hg and Mn in maternal and cord blood
and the sample sizes in many of these studies have been relatively
small (n < 115) (Hu et al., 2015; Chen et al., 2014; García-Esquinas
et al., 2013; Kopp et al., 2012; Kim et al., 2015). There are even
less data available for meconium.
Our results demonstrate that the distribution of these four
metals between maternal and cord blood differed by metal. Cad-
mium was detected in over 96% of maternal bloods, but rarely
detected in cord blood samples. In contrast, Pb and Mn were
detected in almost all maternal and cord blood samples, while Hg
was detected in about 90% of maternal and 72% of cord blood
samples. It is difﬁcult, however, to make a direct comparison of
percentages detected in various matrices given the different LODs
of each method. Median cord blood Pb, Hg and Mn concentrations
were all statistically higher thanmaternal concentrations at 1st and
3rd trimesters, especially for Mn.
The concept of placental transfer of mobilised maternal skeletal
stores of Pb is supported by the similarity of isotopic ratios in
maternal and cord blood reported in a recent study (Gulson et al.,
2016). A German study of mother-infant pairs reported similar
median Pb concentrations in maternal and cord blood, and median
cord Cd below the limit of quantiﬁcation; however, median cord Hg
was about threefold higher than maternal Hg (1.48 vs. 0.44 mg/L)
(Kopp et al., 2012). A Korean study of 104 mother-child pairs also
reported higher Hg (and methylmercury) in cord than in maternal
blood, but not for Pb or Cd; median ratios of cord to 2nd trimesterTotal mercury
airwisea GM (95% CI) p-value Pairwisea GM (95% CI)
0.7549 (0.7273, 0.7836) 0.0065 A 0.8217 (0.7649, 0.8827)
0.7411 (0.7124, 0.7710) B 0.7118 (0.6595, 0.7683)
0.7716 (0.6973, 0.8538) 0.0067 A 0.6245 (0.5147, 0.7579)
0.7601 (0.7121, 0.8113) B 0.8434 (0.7450, 0.9548)
0.7469 (0.7152, 0.7801) B 0.7922 (0.7290, 0.8608)
C 0.8488 (0.7884, 0.9138) 0.2943 0.8262 (0.7153, 0.9544)
0.7879 (0.7304, 0.8499) 0.7331 (0.6316, 0.8510)
B 0.7129 (0.6655, 0.7637) 0.7300 (0.6372, 0.8364)
0.6706 (0.6245, 0.7202) 0.7890 (0.6862, 0.9071)
ups with same letter indicate levels are statistically similar, whereas groups with
Table 4
Maternal blood manganese quartiles and geometric means of other metals from 3rd trimester.
Metal concentration in maternal blood 3rd trimester Potential predictor N p-value Pairwisea GM 95% CI of GM
Manganese concentration in
maternal blood 3rd trimester
Category Range (mg/L)
Cadmium (mg/L) Q1 [<LOD, 9.889] 357 <0.0001 A 0.1651 0.1523 0.1789
Q2 [9.890, 12.6373] 564 AB 0.1847 0.1733 0.1969
Q3 [12.6374, 15.3845] 322 B 0.2036 0.1871 0.2215
Q4 [15.3846, 32.9588] 430 C 0.2435 0.2263 0.2620
Lead (mg/dL) Q1 [<LOD, 9.889] 357 <0.0001 A 0.4946 0.4692 0.5214
Q2 [9.890, 12.6373] 564 B 0.5571 0.5342 0.5810
Q3 [12.6374, 15.3845] 322 BC 0.5944 0.5623 0.6284
Q4 [15.3846, 32.9588] 430 C 0.6499 0.6194 0.6820
Mercury (mg/L) Q1 [<LOD, 9.889] 357 0.0024 A 0.4307 0.3859 0.4806
Q2 [9.890, 12.6373] 564 A 0.4559 0.4178 0.4975
Q3 [12.6374, 15.3845] 322 AB 0.5057 0.4506 0.5676
Q4 [15.3846, 32.9588] 430 B 0.5575 0.5045 0.6160
a Results of statistical hypothesis testing of differences by group characteristics: groups with same letter indicate levels are statistically similar, whereas groups with
different letters represent signiﬁcant differences.
Table 5
Estimated quartiles of maternal calcium intake during 2nd trimester (n ¼ 527 missing) and geometric means of maternal blood metals in the 3rd trimester.
Metal concentration in maternal blood 3rd trimester Potential predictor N p-value Pairwisea GM 95% CI of GM
Total calcium intake (mg/
day)
Cadmium (mg/L) Q1 [147.48, 878.22] 283 0.6050 0.2072 0.1893 0.2269
Q2 [878.23, 1154.69] 285 0.1974 0.1803 0.2160
Q3 [1154.70, 1507.47] 291 0.1898 0.1735 0.2075
Q4 [1507.48, 7318.97] 287 0.1976 0.1806 0.2163
Lead (mg/dL) Q1 [147.48, 878.22] 283 0.0274 A 0.6182 0.5812 0.6575
Q2 [878.23, 1154.69] 285 A 0.6060 0.5699 0.6445
Q3 [1154.70, 1507.47] 291 A 0.5613 0.5281 0.5965
Q4 [1507.48, 7318.97] 287 A 0.5538 0.5209 0.5888
Manganese (mg/L) Q1 [147.48, 878.22] 283 0.4215 12.4830 12.0074 12.9774
Q2 [878.23, 1154.69] 285 12.5615 12.0846 13.0572
Q3 [1154.70, 1507.47] 291 12.2597 11.7989 12.7384
Q4 [1507.48, 7318.97] 287 12.0413 11.5857 12.5148
Mercury (mg/L) Q1 [147.48, 878.22] 283 0.1061 0.5596 0.4947 0.6330
Q2 [878.23, 1154.69] 285 0.4743 0.4195 0.5363
Q3 [1154.70, 1507.47] 291 0.4578 0.4054 0.5169
Q4 [1507.48, 7318.97] 287 0.4772 0.4222 0.5393
a Results of statistical hypothesis testing of differences by group characteristics: groups with same letter indicate levels are statistically similar, whereas groups with
different letters represent signiﬁcant differences.
Table 6
Estimated quartiles of maternal iron intake during 2nd trimester (n ¼ 527 missing) and geometric means of maternal blood metals in the 3rd trimester.
Metal concentration in maternal blood 3rd trimester Potential predictor N p-value Pairwisea GM 95% CI of GM
Total iron intake (mg/
day)
Cadmium (mg/L) Q1 [2.33, 11.85] 276 0.6929 0.2036 0.1857 0.2232
Q2 [11.86, 33.72] 289 0.2018 0.1845 0.2208
Q3 [33.73, 37.15] 288 0.1895 0.1732 0.2074
Q4 [37.16, 337.52] 293 0.1970 0.1802 0.2153
Lead (mg/dL) Q1 [2.33, 11.85] 276 0.8415 0.5848 0.5493 0.6227
Q2 [11.86, 33.72] 289 0.5878 0.5528 0.6250
Q3 [33.73, 37.15] 288 0.5705 0.5365 0.6066
Q4 [37.16, 337.52] 293 0.5927 0.5577 0.6299
Manganese (mg/L) Q1 [2.33, 11.85] 276 0.0177 AB 12.9825 12.4833 13.5016
Q2 [11.86, 33.72] 289 A 12.2184 11.7591 12.6956
Q3 [33.73, 37.15] 288 AC 11.9039 11.4556 12.3696
Q4 [37.16, 337.52] 293 A 12.2818 11.8232 12.7582
Mercury (mg/L) Q1 [2.33, 11.85] 276 0.0539 0.4741 0.4186 0.5371
Q2 [11.86, 33.72] 289 0.4793 0.4243 0.5414
Q3 [33.73, 37.15] 288 0.4490 0.3974 0.5072
Q4 [37.16, 337.52] 293 0.5648 0.5004 0.6374
a Results of statistical hypothesis testing of differences by group characteristics: groups with same letter indicate levels are statistically similar, whereas groups with
different letters represent signiﬁcant differences.
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Table 7
Estimated quartiles of maternal vitamin D intake during 2nd trimester (n ¼ 527 missing) and geometric means of maternal blood metals in the 3rd trimester.
Metal concentration in maternal blood 3rd trimester Potential predictor N p-value Pairwisea GM 95% CI of GM
Total vitamin D intake (IU/
day)
Cadmium (mg/L) Q1 [9.13, 388.88] 280 0.0187b A 0.2133 0.1947 0.2336
Q2 [388.89, 582.92] 286 AB 0.1935 0.1768 0.2117
Q3 [582.93,723.55] 286 AB 0.2001 0.1829 0.2190
Q4 [723.56, 7966.11] 294 B 0.1861 0.1703 0.2035
Lead (mg/dL) Q1 [9.13, 388.88] 280 0.0975 0.6101 0.5733 0.6492
Q2 [388.89, 582.92] 286 0.5883 0.5532 0.6256
Q3 [582.93,723.55] 286 0.5924 0.5570 0.6299
Q4 [723.56, 7966.11] 294 0.5483 0.5161 0.5826
Manganese (mg/L) Q1 [9.13, 388.88] 280 0.0059 AB 12.9505 12.4566 13.4640
Q2 [388.89, 582.92] 286 A 12.2218 11.7605 12.7012
Q3 [582.93,723.55] 286 A 12.4581 11.9878 12.9467
Q4 [723.56, 7966.11] 294 AC 11.7624 11.3244 12.2174
Mercury (mg/L) Q1 [9.13, 388.88] 280 0.4147 0.4684 0.4137 0.5302
Q2 [388.89, 582.92] 286 0.4660 0.4122 0.5269
Q3 [582.93,723.55] 286 0.4982 0.4406 0.5633
Q4 [723.56, 7966.11] 294 0.5302 0.4698 0.5985
a Results of statistical hypothesis testing of differences by group characteristics: groups with same letter indicate levels are statistically similar, whereas groups with
different letters represent signiﬁcant differences.
b The analysis is based on the non-parametric Kruskal Wallis test; the conﬁdence intervals were calculated on the parametric analysis.
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respectively (Kim et al., 2015). Similarly, a South African study also
reported higher Hg in cord blood than in maternal blood (Rudge
et al., 2009). An estimate of the mean cord to maternal blood ra-
tio for methylmercury and inorganic mercury based on a meta-
analysis was 1.89 and 1.01, respectively (Ou et al., 2014). Mercury
in cord blood is primarily methylmercury (Hackett and Kelman,
1983; Kim et al., 2015), and cord blood has about the same level
of inorganic Hg as in maternal blood (Ou et al., 2014). The meth-
ylmercury fraction (usually >98%) of total Hg binds to hemoglobin
(Hb) in erythrocytes (Rudge et al., 2009) and can pass easily
through the placenta to reach the fetus. As Hb levels decrease over
the course of pregnancy (Abbassi-Ghanavati et al., 2009) and are
higher in cord than maternal blood (Lao et al., 1991), this may
explain the disparity between maternal and cord Hg levels, pro-
vided ﬁsh consumption remains unchanged and plasma volume
expansion is considered. The difference in Hg levels could simply
represent a passive equilibrium that is due to binding of methyl-
mercury in Hb rather than an active transfer of metals.
In our study, cord blood median concentrations of Mn (31.87 mg/
L) were over threefold higher than 1st trimester (8.79 mg/L) and 2.5
times higher than 3rd trimester maternal concentrations (12.64 mg/
L). The German study also reported that Mn was about 70% higher
in cord (28.8 mg/L) than maternal blood samples collected at de-
livery (17.0 mg/L), although our 3rd trimester median Mn concen-
trations were considerably higher than the German concentrations
(Kopp et al., 2012). Similar results were also reported in a US
mother-infant pair study (Zota et al., 2009) which reported a 45%
increase between maternal Mn concentrations at delivery and
those in cord blood with a correlation of 0.38. It has been hy-
pothesized that Mn crosses the placenta via active transport;
however, other explanations for the higher Mn concentrations in
cord blood, such as lower or restricted elimination of the element
by the fetus or inability of the fetus to utilize Mn, may account for
this observation (Nandakumaran et al., 2015). Mn was the only
metal that was detected in 100% of the meconium samples in the
MIREC Study which would suggest that the fetus is able to elimi-
nate Mn. While the correlations between maternal or cord blood
MnwithmeconiumMnwere statistically signiﬁcant, they were low
(ranging from 0.13 for 1st trimester to 0.25 for 3rd trimester blood
vs. meconium).4.2. Changes in metal levels throughout pregnancy
In populations with higher mean blood Pb concentrations
(2 mg/dL), Pb concentrations in the same subjects tend to display a
U-shaped curve over three trimesters due to mobilisation of Pb
from the bone to meet increasing demands for Ca (Gulson et al.,
2016; Hertz-Picciotto et al., 2000; Schell et al., 2000; Rothenberg
et al., 1994). However, as seen in our study, populations with a
mean blood Pb concentration <1.2 mg/dL do not display this pattern
(Sowers et al., 2002; Rabito et al., 2014). In addition to variations in
exogenous exposure, blood Pb concentrations can vary due to
changes in hematocrit and Ca levels, plasma volume and to mobi-
lisation of Pb from bones during pregnancy (Gulson et al., 2016).
However, several studies have reported that correcting blood Pb
concentrations for hematocrit did not change their ﬁndings (Gulson
et al., 2016; Hertz-Picciotto et al., 2000; Schell et al., 2000). The
extent of exposure may also determine the relationship between
hematocrit and blood Pb concentrations in pregnancy. La-Llave-
Leon et al. (2015) reported that Hb level, hematocrit, and red
blood cell count were signiﬁcantly higher in pregnant womenwith
a blood Pb concentration  5 mg/dL than in the group with lower
blood Pb concentrations. The extent of plasma volume expansion
during pregnancy may also impact the concentration of Pb
measured in blood later in pregnancy. Maternal blood volume in-
creases (approximately 45%) starting around 6e8 weeks of gesta-
tion and peaks at 32 weeks (Hytten and Paintin, 1963); however,
health conditions such as fetal growth restriction or preeclampsia
may be associated with lower plasma volume expansion (Salas
et al., 2006) and thus affect the interpretation of the results.
Studies that have conducted prospective sampling of Mn levels
during pregnancy are scarce. An early Australian study reported a
signiﬁcant increase in mean whole blood Mn at 10e20 weeks
(8.24 mg/L), 25 weeks (9.43 mg/L), and 34 weeks (12.64 mg/L)
gestation (Spencer, 1999). A study of Costa Rican women reported
that blood Mn concentrations increased signiﬁcantly between the
2nd and 3rd trimesters of pregnancy and calculated an ICC of 0.44
for all three trimesters (Mora et al., 2014). Our study also reported a
signiﬁcant increase in blood Mn between the 1st and 3rd tri-
mesters, with an ICC of 0.29. Approximately 66% of Mn in blood is
bound to the Hb protein in erythrocytes and Mn levels in maternal
erythrocytes have been shown to increase signiﬁcantly over the
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tions later in pregnancy may be attributable to increased intestinal
absorption, which has been reported in later stages of pregnancy in
a rat model (Kirchgessner et al., 1982). While Hb levels decrease
from1st to 3rd trimester (Abbassi-Ghanavati et al., 2009), Mn levels
may increase because of increased absorption and possibly
increased binding capacity towards Hb to ensure sufﬁciency.
An analysis of maternal blood Hg in the ELEMENT Study re-
ported no signiﬁcant difference across the three trimesters and an
ICC of 0.37 (Basu et al., 2014), compared to a signiﬁcant decrease in
maternal Hg in the 3rd trimester and an ICC of 0.60 in MIREC. Blood
volume expansion later in pregnancy may be responsible for lower
concentrations of both Hg and Hb (along with other constituents),
although a reduction in ﬁsh consumption in the 3rd trimester could
also explain the downward trend.
We found no signiﬁcant difference in maternal Cd concentra-
tions over the pregnancy. A Chinese study also reported consistent
blood Cd concentrations across all three trimesters (Liu et al., 2013).
4.3. Comparison of levels of various metals in MIREC and other
studies
A comparison of blood metal concentrations in pregnant
women from various countries, as well as women of reproductive
age in Canada, showed that MIREC women tended to have among
the lowest geometric means for Pb, Cd and Hg (Fig. S4). With the
exception of a study in Costa Rica (Mora et al., 2015), maternal Mn
concentrations in MIREC and other international studies of preg-
nant women were similar and comparable to a Canadian
population-based national survey of women aged 20e39 years
sampled over the same time period (9.8e11 mg/L) (Health Canada,
2010b, 2013b) (Fig. S5). The normal range of blood Mn concentra-
tions in the general population is 4e15 mg/L (ATSDR, 2012). Con-
centrations in MIREC pregnant women ranged from 2 to 33.5 mg/L
and up to 98.9 mg/L in corresponding cord blood samples.
Studies which have measured metals in meconium are rare. A
Japanese study reported trace levels of Pb and to a lesser extent Cd
in meconium (Yang et al., 2013), similar to the results reported in
MIREC. In contrast, studies in high pollution areas of Turkey (Turker
et al., 2006), and the Philippines (Ostrea et al., 2002), as well as
China (Peng et al., 2015) and Taiwan (Jiang et al., 2014) reported
higher metal levels than our study. Concentrations of Mn in
meconium from earlier studies also appear to be substantially
higher (35.8 mg/g at 38e42 weeks gestation) (Haram-Mourabet
et al., 1998) than the concentrations measured in MIREC (median
4.9 mg/g).
4.4. Maternal smoking and blood Mn
Consistent inverse associations have been observed between
maternal smoking and blood Mn concentrations. In MIREC and in a
study of pregnant women from Costa Rica (Mora et al., 2014),
smoking was associated with signiﬁcantly lower maternal blood
Mn concentrations. Similar associations were observed in cord
blood, where maternal smoking was associated with a non-
signiﬁcant but slightly lower GM Mn concentration in our study
and in other smaller studies (Mistry andWilliams, 2011; Jones et al.,
2010). These results are surprising as, in addition to other metals
such as Hg, Cd, Pb, and As (Afridi et al., 2015), cigarette smoke also
contains Mn (Pappas et al., 2014), which might be expected to
result in higher maternal and cord blood Mn concentrations.
Several mechanisms may explainwhy blood Mn concentrations are
lower in smokers. Oxidative stress is a major pathophysiological
factor in the multiple adverse effects of smoking during pregnancy
(Stone et al., 2014). As Mn is an essential nutrient that plays a keyrole in cellular adaptation to oxidative stress (Aguirre and Culotta,
2012), Mn cellular uptake may increase in smokers, resulting in
lower Mn in blood and reduced availability for fetal transfer in
pregnant smokers. In addition, the other metals in smoke such as
Cd can compete with Mn for blood transporters which would lead
to lower blood concentrations. The divalent metal transporter 1
(DMT1) has an afﬁnity not only for Mn but also for other divalent
cations including Fe, cobalt, nickel, Cd, Pb, copper, and zinc
(Kayaaltı et al., 2015).
4.5. Association between relative nutrient intake and maternal and
cord blood metal levels
In our study, the GMmaternal blood Pb concentration in the 3rd
trimester was about 11% lower in the highest compared to the
lowest quartile of relative Ca intake and regression analysis showed
negative correlations between maternal Ca intake and both
maternal and cord blood Pb. In addition to differences in sources
and degree of exposure, nutrient intake may explain some of the
variability in metal concentrations observed in various studies of
pregnant women. Ca intake has been negatively associated with
maternal Pb concentration, although the effect size has been small
(Gulson et al., 2016; Hong et al., 2014; Taylor et al., 2013; Suarez-
Ortegon et al., 2013; Jiang et al., 2011; Zentner et al., 2008). When
blood Ca concentrations are low during pregnancy, more mobi-
lisation from bone is required to meet fetal demands leading to
more Pb also being mobilised from bone (Gulson et al., 2016). In a
randomized placebo-controlled trial in Mexico City where GM
blood Pb was about 4.0 mg/dL, a 1200 mg daily calcium carbonate
supplement was associated with modest reductions in blood Pb
when administered during pregnancy (Ettinger et al., 2009). While
Ca was negatively associated with maternal Cd concentrations in
the regression analysis indicating a small negative linear relation-
ship, there was no signiﬁcant difference in the GMs of Cd when
quartiles of Ca intake were examined. One other study reported no
association between Ca intake and 3rd trimester blood Cd (Suarez-
Ortegon et al., 2013).
Vitamin D intakewas negatively associated with maternal blood
Cd, Pb andMn in the regression analysis but only for Cd did the GMs
for the categories vary signiﬁcantly with the highest quartile of
intake resulting in about 13% reduction in the GM for Cd compared
to the lowest quartile of intake. Regression analysis also suggested
that vitamin D intake was negatively associated with cord blood Pb.
There is limited evidence in the literature of associations between
vitamin D and blood metals. Negative associations have been
observed between maternal dietary intakes of vitamin D and cord
blood Pb (Schell et al., 2003) and 25(OH)D concentration in Chinese
children (Chang et al., 2014). However, an analysis of premeno-
pausal women in the U.S. NHANES found no association between
vitamin D intake and blood Pb (Jackson et al., 2010). Studies
examining vitamin intake and blood Cd are rare with a path anal-
ysis in a cross-sectional study of Korean women showing that
depressed vitamin D levels increased the risk of iron deﬁciency
anemia, and that this anemia increased Cd concentrations in blood
(Suh et al., 2016).
Given the coincidence of sources in maternal diets and the
strong interdependence of both Ca and vitamin D, it is not sur-
prising to observe similar effects on blood metal concentrations.
Higher maternal Fe intake has been associated with lower cord
blood Pb (Schell et al., 2003) and small reductions in maternal
blood Pb (Taylor et al., 2013; Jiang et al., 2011). Maternal blood Cd
was negatively associated with Fe intake in one study (Nishijo et al.,
2004) but showed no association in another (Suarez-Ortegon et al.,
2013). However, no such relationships between Fe intake and blood
Pb or Cd were observed in our study. Women tend to have higher
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may be explained by increased intestinal absorption of dietary Cd
when Fe stores are low (Berglund et al., 1994) and especially during
pregnancy (Åkesson et al., 2002). In our regression analysis, Fe
intake was positively associated with maternal blood Hg, which
agrees with a cross-sectional study of Inuit women from northern
Canada that observed that ferritin was positively correlated with
blood Hg (Plante et al., 2011). This positive association may be
explained by shared major sources of Fe and Hg in the diet of
northern populations. The effect of Fe on Hg levels could also
potentially be impacted by maternal Hb levels. We did not have
reliable complete blood counts to test this hypothesis.
Although we observed a signiﬁcant association between quar-
tiles of Fe intake and maternal blood Mn, no consistent trend was
observed. During conditions of low Fe, abnormal absorption (Finley,
1999) and accumulation of Mn can occur because both share and
compete for many protein transporters responsible for absorption
(Fitsanakis et al., 2010). On the other hand, when Mn concentra-
tions change, the homeostasis and deposition of Fe and other
transition metals are affected (Fitsanakis et al., 2010). Iron/folic acid
supplement use has been associatedwith decreased concentrations
of blood Mn in late pregnancy in a small Australian study (Callan
et al., 2013). However a small clinical trial of Fe supplementation
in pregnancy reported no signiﬁcant difference in blood Mn,
although Fe supplemented women had signiﬁcantly higher con-
centrations of blood Hb and serum ferritin compared to the placebo
group (Tholin et al., 1995). Another study reported that taking Fe
supplements throughout pregnancy increased Mn levels (Spencer,
1999). Increased Mn absorption during pregnancy or change in
how the body distributes or metabolizes Mn during pregnancymay
explain the increased blood Mn concentrations in pregnancy
compared to the non-pregnant state (Tholin et al., 1995). The wide
range of maternal Mn concentrations in whole blood (2e33.5 mg/L)
observed in MIREC may reﬂect different diets, use of supplements
and varying degrees of Fe deﬁciency status among the population,
although the latter could not be measured.
In our study, increasing maternal bloodMn concentrations were
associated with higher blood Cd, Hg and Pb concentrations in the
3rd trimester. Several studies have reported a relationship between
bloodMn and levels of other metals. In an analysis of NHANES data,
a non-linear relationship was observed between blood Mnwith Cd,
Pb and Hg concentrations (Oulhote et al., 2014). A Taiwanese study
has reported that an increase in maternal blood Mn at birth from
the 25th to 75th percentile (15.8e28.4 mg/L) appeared to decrease
the placental transfer of Pb in cord blood by 0.12 mg/dL (Lin et al.,
2010). However, although our quartiles of Mn were lower, we
found no signiﬁcant difference between quartiles of maternal Mn in
the 3rd trimester and cord blood Pb. Maternal blood Pb concen-
trations have also been associated with dose-dependent decreases
in cord Mn (Kopp et al., 2012). The mechanism bywhich Pb reduces
Mn (and Fe) in the fetal unit remains to be ascertained.
4.6. Strengths and limitations
A major strength of this study is the serial collection of bio-
specimens over the pregnancy in several matrices as well as key
information on important covariates that might affect exposure
levels in this population. Although the study population was rela-
tively large and geographically diverse, similar to many observa-
tional studies, participants were on average from a higher socio-
economic stratum (Arbuckle et al., 2013). This limits our ability to
generalize the ﬁndings to other population groups. Our analysis did
not examine genetic variation within the population which could
play a signiﬁcant role in determining metal absorption and distri-
bution. There is also uncertainty associated with the estimation ofdietary nutrient intake. The FFQmay not have captured all potential
sources of these nutrients, therefore may have underestimated
some nutrient intakes. Also, although the FFQ was designed to
obtain relative total intakes of Fe, Ca and vitamin D for Canadian
pregnant women, the estimated intakes from diet and supplements
are not sufﬁcient to determine whether individuals met the daily
recommended intake for these nutrients in pregnancy. Further-
more, there may be other important vitamins (e.g., vitamin C),
minerals (e.g., selenium, phosphorus, magnesium, zinc) and dietary
factors (e.g., fat) that are important for metal toxicokinetics. How-
ever, using these categorized estimates for a few key nutrients, we
demonstrated in a large sample of pregnant women from across
Canada that estimated intakes from diet and supplements were
associated with some maternal blood metal concentrations.
4.7. Summary, recommendations and conclusions
The MIREC Study offers a unique opportunity to estimate fetal
exposure to environmental chemicals of interest in utero: 1) indi-
rectly, by assessing the nature and degree of maternal exposure
through measurement of metals in blood samples and 2) directly,
bymeasuringmetal concentrations in cord blood andmeconium. In
general, with the exception of 3rd trimester Mn, blood metal con-
centrations were lower in MIREC than in the general population of
women aged 20e39 in Canada. As our study and others (Spencer,
1999; Tsai et al., 2015; Mora et al., 2015) have shown, blood Mn
concentrations increase over the course of the pregnancy, although
guidelines on appropriate levels in pregnancy are not available.
Our results suggest placental transfer of Cd is limited, Pb can
cross easily and Hg and Mn may accumulate in cord blood. This
latter conclusion is further strengthened by examining metal con-
centrations in meconium, where Cd was detected in only 3%, Pb in
20%, Hg in 25% and Mn in 100% of the samples. There are likely
different modes of action for placental transfer of Pb and Hg, with
one group suggesting more active transport of Hg to the fetus,
while Pb transfer may be more passive (Gundacker et al., 2010).
However, given the binding of methylmercury to Hb, active trans-
port of Hgmay be less plausible. Maternal-fetal transfer of metals is
a major source of early life exposure for Cd, Hg and Pb (Chen et al.,
2014). Large variability in maternal and fetal exposure levels were
observed in our study, suggesting both individual differences in
exposure and heterogeneity in placental transfer. Nonetheless,
minimizing maternal exposure will reduce fetal exposure.
Given the probability of maternal-fetal metal transfer and the
heightened health concerns due to the sensitivity of a developing
fetus to the presence of such metals, more effort needs to be
expended to both establish national/international guidelines and to
identify vulnerable populations and individuals at risk. A recent
paper has reiterated the need for international consensus on levels
of concern for Pb, Cd and Hg exposure during pregnancy, which
requires ongoing monitoring of levels in pregnant women (Taylor
et al., 2014) and prospective studies of potential health effects in
the pregnant woman and her child. In addition, normative con-
centrations for blood Mn during pregnancy need to be established
(Kopp et al., 2012).
To date, no agency has proposed guidelines for blood Hg con-
centrations in pregnant women. In Canada, a provisional blood
guidance value of 8 mg/L for methylmercury has been proposed for
children, pregnant women and women of childbearing age
(Legrand et al., 2010). The U.S. EPA reference dose for methylmer-
cury is 0.1 mg/kg/day (https://cfpub.epa.gov/ncea/risk/recordisplay.
cfm?deid¼20873&CFID¼55941601&CFTOKEN¼41278506,
accessed April 6, 2016) associatedwith a cord bloodmethylmercury
value of 5.8 mg/L (National Research Council, 2000). Canadian aca-
demic researchers have concluded that a proposed
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a pregnancy would be highly cost-effective from a societal
perspective (Gaskin et al., 2015). These researchers used an inter-
vention level equal to the threshold for adverse neuro-
developmental effects of 3.4 mg/L in maternal blood and
recommended that women replace high Hg ﬁsh in their diet with
low Hg/high polyunsaturated fatty acid ﬁsh (Gaskin et al., 2015).
Fewer than 5% of the MIREC women had a blood Hg concentration
exceeding 3.4 mg/L. American (U.S. FDA, 2014) and Canadian (Health
Canada, 2011) agencies have recommended that pregnant women
and women of childbearing age limit consumption of certain types
of ﬁsh that may have higher Hg concentrations.
The U.S. Occupational Safety and Health Administration blood
Cd threshold for intervention for employees is 5 mg/L (https://www.
osha.gov/Publications/osha3136.pdf, accessed August 11, 2015) and
the threshold for Pb intervention in pregnant women promoted by
the U.S. CDC is 5 mg/dL (http://www.cdc.gov/nceh/lead/
publications/leadandpregnancy2010.pdf, accessed August 11,
2015). No threshold for intervention for blood Mn could be found.
Our results, consistent with some of the literature, provide some
support that at even at current levels, higher Ca and vitamin D
intake can be associated with lower maternal blood Pb and Cd
concentrations. However, the potential beneﬁts of increasing intake
of vitamin D (or Ca) on maternal metal concentrations needs to be
further studied, given that others have suggested that excessive
vitamin D intake may enhance absorption of toxic metals
(Schwalfenberg and Genuis, 2015; Moon, 1994).
Future research on this prospective cohort and other similar
cohorts will generate the potential health effects data needed to
develop policy on blood metal concentrations in pregnancy and to
establish normative concentrations of blood Mn during pregnancy.
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